IL-6 antibodies
US11142571B2 · kind B2 · utility
0Cited by
36References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2015 |
| Grant date | Oct 12, 2021 |
| Priority date | — |
| Expiry date | Aug 14, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Improved IL-6 antibodies are provided. Uses of the antibodies in the treatment of IL-6-related diseases, e.g., ocular diseases such as diabetic macular edema, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.